|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.01 CHF | +0.74% |
|
-2.36% | -2.36% |
| 07-16 | Truist Adjusts Price Target on DexCom to $87 From $80, Maintains Buy Rating | MT |
| 07-16 | Abbott raises 2026 profit forecast on heart device strength | RE |
Upcoming events on DexCom, Inc.
| 2026-07-30 | Earnings release - Q2 2026 | |
| 2026-07-30 | Earnings presentation | 16:30 |
Past events on DexCom, Inc.
| 2026-05-27 | Présentation aux Actionnaires / Analystes | 17:00 |
| 2026-05-26 | Annual General Meeting | |
| 2026-05-14 | Analyst/Investor Day | 16:15 |
| 2026-04-30 | Earnings presentation | 16:30 |
| 2026-04-30 | Earnings release - Q1 2026 | |
| 2026-02-12 | Earnings release - Q4 2025 | |
| 2026-02-12 | Earnings presentation | 16:30 |
| 2025-10-30 | Earnings presentation | 16:30 |
| 2025-10-30 | Earnings release - Q3 2025 | |
| 2025-07-30 | Earnings presentation | 16:30 |
| 2025-07-30 | Earnings release - Q2 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 622 3 610 0.35% | 4 033 4 023 0.25% | 4 662 4 655 0.15% | 5 224 | 5 827 | 6 507 |
|
EBITDA Million USD | Released Forecast Spread | 1 015 1 007 0.73% | 1 105 1 152 -4.1% | 1 349 1 355 -0.47% | 1 638 | 1 914 | 2 209 |
|
EBIT Million USD | Released Forecast Spread | 719 687 4.59% | 757 783 -3.34% | 969 942 2.85% | 1 212 | 1 438 | 1 726 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 710 632 12.49% | 709 805 -11.89% | 1 088 1 047 3.96% | 1 256 | 1 476 | 1 716 |
|
Net income Million USD | Released Forecast Spread | 542 445 21.74% | 576 634 -9.08% | 836 830 0.76% | 959 | 1 157 | 1 383 |
|
EPS USD | Released Forecast Spread | 1,30 1,09 19.66% | 1,42 1,54 -7.79% | 2,09 2,07 0.95% | 2,45 | 2,92 | 3,51 |
| Announcement Date | 08/02/24 | 13/02/25 | 12/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 994 991 0.3% | 1 114 1 104 0.88% | 1 036 1 017 1.83% | 1 157 1 125 2.89% | 1 209 1 178 2.62% | 1 260 1 254 0.45% | 1 192 1 175 1.46% | 1 290 | 1 335 | 1 405 | 1 322 | 1 435 | 1 484 | 1 553 | 1 480 |
|
EBITDA Million USD | Released Forecast Spread | 300 307 -2.35% | 300 348 -13.66% | 230 252 -8.53% | 328 315 4.13% | 368 379 -2.76% | 422 426 -0.78% | 365 314 16% | 390 | 424 | 461 | 408 | 454 | 492 | 536 | 503 |
|
EBIT Million USD | Released Forecast Spread | 212 211 0.45% | 210 237 -11.59% | 143 148 -3.61% | 222 209 6.27% | 273 270 1.24% | 332 309 7.45% | 264 217 21.62% | 284 | 314 | 352 | 291 | 335 | 374 | 419 | 376 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 177 225 -21.24% | 211 262 -19.41% | 154 163 -5.36% | 241 236 1.97% | 352 292 20.75% | 341 336 1.36% | 270 234 15.05% | 305 | 328 | 361 | 306 | 353 | 385 | 423 | |
|
Net income Million USD | Released Forecast Spread | 135 170 -20.92% | 152 199 -23.91% | 105 123 -14.29% | 180 172 4.49% | 284 223 27.44% | 267 260 2.66% | 200 182 9.47% | 232 | 258 | 282 | 234 | 270 | 294 | 324 | |
|
EPS USD | Released Forecast Spread | 0,34 0,41 -17.31% | 0,38 0,48 -21.15% | 0,27 0,31 -12.22% | 0,45 0,43 5.52% | 0,70 0,55 26.85% | 0,68 0,65 3.93% | 0,51 0,45 12.62% | 0,60 | 0,65 | 0,73 | 0,62 | 0,71 | 0,77 | 0,86 | |
| Announcement Date | 24/10/24 | 13/02/25 | 01/05/25 | 30/07/25 | 30/10/25 | 12/02/26 | 30/04/26 | - | - | - | - | - | - | - | - |
| 2026-07-20 | Extraordinary General Meeting | 03:00 | |
| 2026-07-20 | Extraordinary General Meeting | 02:30 | |
| 2026-07-21 | Earnings release - Q2 2026 | ||
| 2026-07-21 | Earnings presentation | 04:00 | |
| 2026-07-22 | Extraordinary General Meeting | 09:00 | |
| 2026-07-23 | Earnings presentation | 08:00 | |
| 2026-07-23 | Earnings release - Q2 2026 | ||
| 2026-07-23 | Earnings release - Q2 2026 | ||
| 2026-07-23 | Annual General Meeting | ||
| 2026-07-23 | Earnings release - Q2 2026 |
Past sector events for DexCom, Inc.
| 2026-07-16 | Earnings release - Q2 2026 | ||
| 2026-07-16 | Earnings presentation | 09:00 | |
| 2026-07-16 | Earnings release - Q2 2026 | ||
| 2026-07-16 | Earnings presentation | 03:00 | |
| 2026-07-16 | Extraordinary General Meeting | 02:00 | |
| 2026-07-15 | Ex-dividend date - 0.63 USD | 00:00 | |
| 2026-07-15 | Board of Directors Meeting | ||
| 2026-07-15 | Earnings presentation | 03:30 | |
| 2026-07-15 | Earnings release - Q3 2026 | ||
| 2026-07-14 | Earnings release - Q2 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Calendar DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
















